@incollection{, 5717F41510B40787BC8964DB1A4DA2F5 , note={Type: Double Blind Peer Reviewed International Research Journal Publisher: Global Journals Inc. (USA)} , author={{Peter H.Tang} and {University of Cincinnati College of Medicine}}, journal={{Global Journal of Medical Research}}, journal={{GJMR}}2249-46180975-588810.34257/GJMR, address={Cambridge, United States}, publisher={Global Journals Organisation}17319 } @incollection{b0, , title={{Voriconazole: a new triazole antifungal agent}} , author={{ LBJohnson } and { CAKauffman }} , journal={{Clin. Infect. Dis}} 36 , year={2003} } @incollection{b1, , title={{CYP2C19 genotype is a major factor contributing to the highly variable pharmacokinetics of voriconazole}} , author={{ JWeiss } and { MMTen Hoevel } and { JBurhenne } and { IWalter-Sack } and { MMHoffmann } and { JRengelshausen } and { WEHaefeli } and { GMikus }} , journal={{J. Clin. Pharmacol}} 49 , year={2009} } @incollection{b2, , title={{Pharmacokinetics and safety of voriconazole following intravenous-to oral-dose escalation regimens}} , author={{ LPurkins } and { NWood } and { PGhahramani } and { KGreenhalgh } and { MJAllen } and { DKleinermans }} , journal={{Antimicrob. Agents Chemother}} 46 , year={2002} } @incollection{b3, , title={{Voriconazole serum concentrations in obese and overweight immunocompromised patients: a retrospective review}} , author={{ SDavies-Vorbrodt } and { JIIto } and { BRTegtmeier } and { SSDadwal } and { JKriengkauykiat }} , journal={{Pharmacotherapy}} 33 , year={2013} } @incollection{b4, , title={{Voriconazole dosing and therapeutic drug monitoring in children: experience from a paediatric tertiary care centre}} , author={{ ABoast } and { NCurtis } and { NCranswick } and { AGwee }} , journal={{J. Antimicrob. Chemother}} 71 , year={2016} } @incollection{b5, , title={{A retrospective analysis of patient-specific factors on voriconazole clearance}} , author={{ SDote } and { MSawai } and { ANozaki } and { KNaruhashi } and { YKobayashi } and { HNakanishi }} , journal={{J. Pharm. Health Care Sci}} 2 10 , year={2016} } @incollection{b6, , title={{Effect of cytochrome P450 2C19 genotype on voriconazole exposure in cystic fibrosis lung transplant patients}} , author={{ MBerge } and { RGuillemain } and { DATrégouet } and { CAmrein } and { VBoussaud } and { PChevalier } and { ALillo-Lelouet } and { CLe Beller } and { PLaurent-Puig } and { PHBeaune } and { EMBillaud } and { MALoriot }} , journal={{Eur. J. Clin. Pharmacol}} 67 , year={2011} } @incollection{b7, , title={{Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics}} , author={{ JRengelshausen } and { MBanfield } and { KDRiedel } and { JBurhenne } and { JWeiss } and { TThomsen } and { IWalter-Sack } and { WEHaefeli } and { GMikus }} , journal={{Clin. Pharmacol. Ther}} 78 , year={2005} } @incollection{b8, , title={{Prolonged half-life of voriconazole in a CYP2C19 homozygous poor metabolizer receiving vincristine chemotherapy: avoiding a serious adverse drug interaction}} , author={{ BMoriyama } and { OFalade-Nwulia } and { JLeung } and { SRPenzak } and { CJjingo } and { XHuang } and { SAHenning } and { WHWilson } and { TJWalsh }} , journal={{Mycoses}} 54 , year={2011} } @incollection{b9, , title={{Multicenter study of voriconazole pharmacokinetics and therapeutic drug monitoring}} , author={{ MJDolton } and { JERay } and { SCChen } and { KNg } and { LGPont } and { AJMclachlan }} , journal={{Antimicrob. Agents Chemother}} 56 , year={2012} } @incollection{b10, , title={{Validation of an assay for voriconazole in serum samples using liquid chromatography-tandem mass spectrometry}} , author={{ BGKeevil } and { SNewman } and { SLockhart } and { SJHoward } and { CBMoore } and { DWDenning }} , journal={{Ther. Drug Monit}} 26 , year={2004} } @incollection{b11, , title={{Fast, fully automated analysis of voriconazole from serum by LC-LC-ESI-MS-MS with parallel column-switching technique}} , author={{ HEgle } and { RTrittler } and { AKönig } and { KKümmerer }} , journal={{J. Chromatogr. B Analyt. Technol. Biomed. Life Sci}} 814 , year={2005} } @incollection{b12, , title={{Quantification of voriconazole in plasma by liquid chromatography-tandem mass spectrometry}} , author={{ MVogeser } and { XSchiel } and { USpöhrer }} , journal={{Clin. Chem. Lab. Med}} 43 , year={2005} } @incollection{b13, , title={{Development, validation, and routine application of a high-performance liquid chromatography method coupled with a single mass detector for quantification of itraconazole, voriconazole, and posaconazole in human plasma}} , author={{ LBaietto } and { AD'avolio } and { GVentimiglia } and { FGDerosa } and { MSiccardi } and { MSimiele } and { MSciandra } and { GDiperri }} , journal={{Antimicrob. Agents Chemother}} 54 , year={2010} } @incollection{b14, , title={{Multiplex ultraperformance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, voriconazole-N-oxide, anidulafungin, and caspofungin}} , author={{ LADecosterd } and { BRochat } and { BPesse } and { TMercier } and { FTissot } and { NWidmer } and { JBille } and { TCalandra } and { BZanolari } and { OMarchetti }} , journal={{Antimicrob. Agents Chemother}} 54 , year={2010} } @incollection{b15, , title={{Development and validation of a new method to simultaneously quantify triazoles in plasma spotted on dry sample spot devices and analysed by HPLC-MS}} , author={{ LBaietto } and { AD'avolio } and { CMarra } and { MSimiele } and { JCusato } and { SPace } and { AAriaudo } and { FGDerosa } and { GDiperri }} , journal={{J. Antimicrob. Chemother}} 67 , year={2012} } @incollection{b16, , title={{Determination of voriconazole in human plasma and saliva using high-performance liquid chromatography with fluorescence detection}} , author={{ CMichael } and { JTeichert } and { RPreiss }} , journal={{J. Chromatogr. B Analyt. Technol. Biomed. Life Sci}} 865 , year={2008} } @book{b17, , title={{Quantification of voriconazole in human bronchoalveolar lavage fluid using high-performance liquid chromatography with}} , author={{ SHeng } and { RLNation } and { BLevvey } and { GISnell } and { MASlavin } and { DC MKong }} , year={2013} } @incollection{b18, , title={{Effects of erythromycin on voriconazole pharmacokinetics and association with CYP2C19 polymorphism}} , author={{ HYShi } and { JYan } and { WHZhu } and { GPYang } and { ZRTan } and { WHWu } and { GZhou } and { XPChen } and { DSOuyang }} , journal={{Eur. J. Clin. Pharmacol}} 66 , year={2010} }